Correction
After publication of the article [1], it has been brought to our attention that there is a nomenclature issue with this article. At the time of acceptance, the VARS2 mutation was considered equivalent to the VARS mutation. However, this has changed so that VARS2 now only refers to shorter mitochondrial sequence of valyl-tRNA synthesase containing 1093 amino acids. Therefore, in the context of this article, every usage of “VARS2” should be replaced with “VARS” when referring to the causative variant.
Reference
Alsemari A, Al-Younes B, Goljan E, Jaroudi D, BinHumaid F, Meyer B, et al. Recessive VARS2 mutation underlies a novel syndrome with epilepsy, mental retardation, short stature, growth hormone deficiency, and hypogonadism. Hum Genomics. 2017;11(1):28. https://doi.org/10.1186/s40246-017-0124-4.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1186/s40246-017-0130-6
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Alsemari, A., Al-Younes, B., Goljan, E. et al. Correction to: Recessive VARS2 mutation underlies a novel syndrome with epilepsy, mental retardation, short stature, growth hormone deficiency, and hypogonadism. Hum Genomics 11, 33 (2017). https://doi.org/10.1186/s40246-017-0130-6
Published:
DOI: https://doi.org/10.1186/s40246-017-0130-6